TM Capital

JULY 17, 2024

Josh Mastracci has joined TM Capital as a Director in the firm’s Healthcare practice. Josh has extensive experience completing transactions across key healthcare services sectors including physician practice management, ambulatory surgery centers, and pharmaceutical services. in Economics from Boston College, a J.D. Success.

Capital 52

Capital Pharmaceutical Private Equity Healthcare 52

How2Exit

OCTOBER 2, 2023

Damon emphasizes the value of leveraging technology, such as AI and automation, in industries like e-commerce and healthcare. rn Leveraging technology, such as AI and automation, can significantly improve efficiency and quality in industries like e-commerce and healthcare. And how do you compare to that?

Mergers and Acquisitions 130

Mergers and Acquisitions Business M&A Mergers 130

Software Equity Group

MAY 7, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Software Equity Group

MAY 8, 2024

2023 saw a myriad of factors impact SaaS M&A multiples, including economic developments, technological advancements, and a public market rebound. In any given year, however, some sectors of the SaaS universe are more prosperous than others, depending on industry trends, global economics, and other influences.

M&A 52

M&A Valuation Economics Business 52

Focus Investment Banking

JUNE 13, 2023

As we’ve seen in other healthcare verticals, PE interest is driven by the opportunity to provide growth capital, contribute management expertise, and consolidate a fragmented industry to increase efficiency. Founded in 2007, publicly-traded TOI provides care to about 1.8 Alliance Health Services. Tahoe still owns a minority interest.

Hospitality 52

Hospitality Private Equity Mergers and Acquisitions Medical 52

Software Equity Group

MARCH 13, 2023

In terms of the target market, the top five SaaS verticals were led by Healthcare, as more and more companies in the healthcare sector turn to SaaS solutions to improve patient care and manage costs. Strategic buyers are publicly traded or privately owned software companies. In 2022, verticals made up 42%, a slight increase.

M&A 52

M&A Private Equity Equities S&P 52

Cooley M&A

JANUARY 25, 2023

Biopharmaceutical company Chimerix agreed to sell its worldwide rights to brincidofovir, including TEMBEXA, to Emergent BioSolutions in a transaction intended to enhance Chimerix’s balance sheet while allowing Chimerix to participate in the longer-term economics of the drug through milestone payments and royalties.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40